Generic Product News: January 2024

Pharmacy TimesJanuary 2024
Volume 90
Issue 1

The products include Loteprednol Etabonate Ophthalmic Suspension, Teriparatide Injection, Allopurinol Tablets, and Sitagliptin Tablets.

Loteprednol Etabonate Ophthalmic Suspension, 0.2%

From: Lupin

Compare to: Alrex

The FDA has given the green light to Lupin’s generic loteprednol etabonate ophthalmic suspension, 0.2%, a generic alternative to Bausch & Lomb’s Alrex. The suspension is indicated for temporary relief of the signs and symptoms of seasonal allergic conjunctivitis, including redness and itching in the eyes, watery discharge, and acute discomfort in bright sunlight. The conjunctiva may also become swollen and look purple, which can interfere with vision clarity. According to IQVIA data in October 2023, Alrex had a market value of approximately 29.1% million.


Teriparatide Injection

From: Teva

Compare to: Forteo

Teva has launched teriparatide injection, a generic of Forteo. The injection is indicated to treat postmenopausal women who have osteoporosis and are at a heightened risk for fractures or who cannot tolerate other osteoporosis treatments. The injection can decrease the change of fractures in the spine and other bones. It is also indicated to increase bone mass in men with primary or hypogonadal osteoporosis who are at high risk for fractures, and for both men and women with osteoporosis as a result of glucocorticoid medicines, such as prednisone, for several months.


Allopurinol Tablets, 100 mg and 300 mg

From: Lupin

Compare to: Zyloprim

Lupin has received FDA clearance for allopurinol tablets, 100 mg and 300 mg. The tablets are indicated for adults with signs and symptoms of primary or secondary gout, including acute attacks, tophi, joint destruction, uric acid lithiasis, and/or nephropathy. Additionally, it is indicated for adult and pediatric patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anticancer therapies that cause elevated serum and urinary uric acid levels; and adults with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in men and 750 mg/day in women, despite lifestyle changes.


Sitagliptin Tablets, 25 mg, 50 mg, and 100 mg

From: Lupin

Compare to: Januvia

Lupin’s generic sitagliptin tablets have been given FDA clearance in dosages 25 mg, 50 mg, and 100 mg. The tablets are indicated as an adjunct therapy to diet and exercise to improve glycemic control in patients with type 2 diabetes. As a dipeptidyl peptidase-4 inhibitor, sitagliptin helps manage blood sugar levels by increasing substances in the body that make the pancreas release more insulin and signals the liver to stop producing glucose when there is too much sugar in the blood.


Related Videos
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg -
Image credit: |
Medical team -- Image credit: Flamingo Images |
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin -
© 2024 MJH Life Sciences

All rights reserved.